Curis, Inc.
Nasdaq CRIS · Lexington, MA
Works in Genetic & rare · Hematology · Immunology · Neurology · Oncology
Curis, Inc. is a clinical trial sponsor based in Lexington, MA, listed as Nasdaq CRIS. It has 2 active clinical trials with 260 planned participants, across 5 therapeutic areas. Since 2021 it has completed 3 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq CRIS
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Curis, Inc
Curis, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 260 planned participants, in Genetic & rare, Hematology, Immunology, Neurology and other areas. Since 2021 it has completed 3 trials and stopped 1 early.
Curis, Inc is based in Lexington, MA and is listed as Nasdaq CRIS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Curis, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-06.
Approve Suite is not affiliated with Curis, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.